Learn more

Every year, 10 million people die unnecessarily because they lack access to existing medical treatments; high prices and legal barriers are often contributing factors. A further billion people are infected with one or more so-called “neglected” diseases, for which safe and effective treatments have not been developed because the sufferers are too poor to provide an economic incentive.

In both cases, universities are well-placed to make a difference. University scientists are major contributors to the drug development pipeline. At the same time, universities are commited to advancing the public good.

	Watch talks online From TEDxTerryTalks 2008: “Making medicines for people, not for profit” by Mike Gretes (22:57) slides | script | video
Read about… Access to Essential Medicines Neglected Diseases and the Research Gap International Patent Law History of UAEM at UBC UILO: Principles for Global Access to UBC Technologies Glossary	In-depth UBC course HESO 449B: Increasing Access to Essential Medicines a student-directed seminar by Sonja Babovic Spring 2010
Seminars (slides and handouts) 2011 2010 2009 2008 2007